Product correctly added to cart.

discount label
Nevirapine Related Compound A
View 3D

Biosynth logo

Nevirapine Related Compound A

CAS: 133627-17-5

Ref. 3D-IFA62717

25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 10 Jan 2025

Product Information

Name:
Nevirapine Related Compound A
Synonyms:
  • 6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-4-methyl-
Description:

Nevirapine Related Compound A is a pharmaceutical preparation that belongs to the class of liquid chromatography methods. It is a photolytic, harmonisation, and regression method for determining impurities in products containing nevirapine. The method is based on reversed-phase high-performance liquid chromatography with ultraviolet detection at 254 nm. The peroxide content of nevirapine related compound A has been determined to be less than 1 ppm by the diastereomeric purity test. Nevirapine Related Compound A contains no salicylic acid or chromatographic impurities.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
254.29 g/mol
Formula:
C14H14N4O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IFA62717 Nevirapine Related Compound A

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".